Trial Profile
Comparison of Eptacog alfa biosimilar (Aryoseven) versus Eptacog alfa (Novoseven) in patients with hemophilia A
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Apr 2015
Price :
$35
*
At a glance
- Drugs Eptacog alfa (Primary)
- Indications Haemophilia A
- Focus Therapeutic Use
- 09 Apr 2015 New trial record